A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

Johnson & Johnson is advancing Alzheimer’s research through precision medicine, focusing on tau-targeting therapies like ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...

Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

A new study showed that people who took longer to enter this dream phase of sleep had higher levels of amyloid beta and tau, ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

My 89-year-old husband was diagnosed with Alzheimer's disease. He does not take any medication. He is in excellent health ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

A once-a-day pill that could be the “holy grail” in the treatment of Alzheimer’s disease is a step closer to becoming a ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...